Whitehawk Therapeutics
(NASDAQ) WHWK
Whitehawk Therapeutics Financials at a Glance
Market Cap
$160.00M
Revenue (TTM)
$7.14M
Net Income (TTM)
$20.60M
EPS (TTM)
$0.47
P/E Ratio
7.14
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$3.39
Volume
68,234
Open
$3.58
Price
$3.39
Volume
68,234
Open
$3.58
Previous Close
$3.39
Daily Range
$3.35 - $3.63
52-Week Range
$1.39 - $4.48
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$3.39
Volume
68,234
Open
$3.58
Previous Close
$3.39
Daily Range
$3.35 - $3.63
52-Week Range
$1.39 - $4.48
WHWK News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Whitehawk Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
23
CEO
David Lennon, PhD
Website
www.whitehawktx.comHeadquarters
Pacific Palisades, CA 90272, US
WHWK Financials
Key Financial Metrics (TTM)
Gross Margin
89%
Operating Margin
-16%
Net Income Margin
-3%
Return on Equity
-22%
Return on Capital
-84%
Return on Assets
-14%
Earnings Yield
14.01%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$160.00M
Shares Outstanding
47.20M
Volume
68.23K
Short Interest
0.00%
Avg. Volume
160.30K
Financials (TTM)
Gross Profit
$6.38M
Operating Income
$114.40M
EBITDA
$114.40M
Operating Cash Flow
$97.43M
Capital Expenditure
$552.00K
Free Cash Flow
$97.98M
Cash & ST Invst.
$145.70M
Total Debt
$0.00
Whitehawk Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$1.00K
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$160.00M
N/A
Market Cap/Employee
$4.00M
N/A
Employees
40
N/A
Net Income
$23.25M
-27.2%
EBITDA
$24.89M
-36.5%
Quarterly Fundamentals
Net Cash
$145.70M
+214.0%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
-100.0%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-13.66%
N/A
Return on Invested Capital
-83.93%
N/A
Free Cash Flow
$17.23M
-13.1%
Operating Cash Flow
$17.23M
-14.5%